- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Essential medicines for breast cancer in low and middle income countries ; volume:15 ; number:1 ; day:18 ; month:8 ; year:2015 ; pages:1-8 ; date:12.2015
BMC cancer ; 15, Heft 1 (18.8.2015), 1-8, 12.2015
- Urheber
-
Bazargani, Y. T.
- Beteiligte Personen und Organisationen
-
de Boer, A.
Schellens, J. H. M.
Leufkens, H. G. M.
Mantel-Teeuwisse, Aukje K.
SpringerLink (Online service)
- DOI
-
10.1186/s12885-015-1583-4
- URN
-
urn:nbn:de:1111-2016110620419
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bazargani, Y. T.
- de Boer, A.
- Schellens, J. H. M.
- Leufkens, H. G. M.
- Mantel-Teeuwisse, Aukje K.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Selection of essential medicines for the prevention and treatment of cardiovascular diseases in low and middle income countries
Access to cardiovascular medicines in low- and middle-income countries: a mini review
Medicines patents, access and innovation : the growing challenges for people in low and middle-income countries to access new medicines
Comparison of medicines management strategies in insurance schemes in middle-income countries: four case studies
Measuring the middle class in middle income countries
Availability, prices, and affordability of selected essential cancer medicines in a middle-income country – the case of Mexico
Future information technology tools for fighting substandard and falsified medicines in low- and middle-income countries
Fighting poor-quality medicines in low- and middle-income countries: the importance of advocacy and pedagogy
Forming a medicines pricing policy for low and middle-income countries (LMICs): the case for Pakistan
Child Poverty in Middle-Income Countries
Developing and Distributing Essential Medicines to Poor Countries: The DEFEND Proposal
Three essays on the procurement of essential medicines in developing countries
Selection of essential medicines for the prevention and treatment of cardiovascular diseases in low and middle income countries
Access to cardiovascular medicines in low- and middle-income countries: a mini review
Medicines patents, access and innovation : the growing challenges for people in low and middle-income countries to access new medicines
Comparison of medicines management strategies in insurance schemes in middle-income countries: four case studies
Measuring the middle class in middle income countries
Availability, prices, and affordability of selected essential cancer medicines in a middle-income country – the case of Mexico
Future information technology tools for fighting substandard and falsified medicines in low- and middle-income countries
Fighting poor-quality medicines in low- and middle-income countries: the importance of advocacy and pedagogy
Forming a medicines pricing policy for low and middle-income countries (LMICs): the case for Pakistan
Child Poverty in Middle-Income Countries
Developing and Distributing Essential Medicines to Poor Countries: The DEFEND Proposal
Three essays on the procurement of essential medicines in developing countries
Selection of essential medicines for the prevention and treatment of cardiovascular diseases in low and middle income countries
Access to cardiovascular medicines in low- and middle-income countries: a mini review
Medicines patents, access and innovation : the growing challenges for people in low and middle-income countries to access new medicines
Comparison of medicines management strategies in insurance schemes in middle-income countries: four case studies
Measuring the middle class in middle income countries
Availability, prices, and affordability of selected essential cancer medicines in a middle-income country – the case of Mexico
Future information technology tools for fighting substandard and falsified medicines in low- and middle-income countries
Fighting poor-quality medicines in low- and middle-income countries: the importance of advocacy and pedagogy
Forming a medicines pricing policy for low and middle-income countries (LMICs): the case for Pakistan
Child Poverty in Middle-Income Countries
Developing and Distributing Essential Medicines to Poor Countries: The DEFEND Proposal